Literature DB >> 31372735

Optimizing 3D FLAIR to detect MS lesions: pushing past factory settings for precise results.

Augustin Lecler1, C Bouzad2,3, R Deschamps4, F Maizeroi2, J C Sadik2, A Gueguen4, O Gout4, H Picard5, J Savatovsky2.   

Abstract

BACKGROUND: To assess the diagnostic value of three 3D FLAIR sequences with differing repetition-times (TR) at 3-Tesla when detecting multiple sclerosis (MS) lesions.
METHODS: In this prospective study, approved by the institutional review board, 27 patients with confirmed MS were prospectively included. One radiologist performed manual segmentations of all high-signal intensity lesions using three 3D FLAIR data sets with different TR of 4800 ms ("FLAIR4800"), 8000 ms ("FLAIR8000") and 10,000 ms ("FLAIR10,000") and two radiologists double-checked it. The main judgment criterion was the overall number of lesions; secondary objectives were the assessment of lesion location, as well as measuring contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR). A non-parametric Wilcoxon's test was used to compare the differing FLAIR.
RESULTS: The FLAIR8000 and FLAIR10,000 detected significantly more overall lesions per patient as compared with the FLAIR4800 [116.1 (± 61.7) (p = 0.02) and 115.8 (± 56.3) (p = 0.03) versus 99.2 (± 66.9), respectively]. The FLAIR8000 and FLAIR10,000 detected four and eight times more cortical or juxta-cortical lesions per patient as compared with FLAIR4800 [1.6 (± 2.2) (p = 0.001) and 4.1 (± 5.9) (p = 6 × 10-5) versus 0.4 (± 1.1), respectively]. CNR was significantly correlated to the TR value. It was significantly higher with FLAIR10,000 than it was with FLAIR8000 and FLAIR4800 [16.3 (± 3.5) versus 15 (± 2.4) (p = 0.01) and 12 (± 2.2) (p = 2 × 10-6), respectively]
CONCLUSION: An optimized 3D FLAIR with a long TR significantly improved both overall lesion detection and CNR in MS patients as compared to a 3D FLAIR with factory settings.

Entities:  

Keywords:  Diagnosis; Diagnostic imaging; Magnetic resonance imaging; Multiple sclerosis

Mesh:

Year:  2019        PMID: 31372735     DOI: 10.1007/s00415-019-09490-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Brain lesions: when should fluid-attenuated inversion-recovery sequences be used in MR evaluation?

Authors:  T Okuda; Y Korogi; Y Shigematsu; T Sugahara; T Hirai; I Ikushima; L Liang; M Takahashi
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

2.  Serial isotropic three-dimensional fast FLAIR imaging: using image registration and subtraction to reveal active multiple sclerosis lesions.

Authors:  I Leng Tan; Ronald A van Schijndel; Petra J W Pouwels; Herman J Adèr; Frederik Barkhof
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

3.  3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis.

Authors:  Paul Polak; Christopher Magnano; Robert Zivadinov; Guy Poloni
Journal:  Magn Reson Med       Date:  2011-12-02       Impact factor: 4.668

4.  Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.

Authors:  M P Wattjes; G G Lutterbey; J Gieseke; F Träber; L Klotz; S Schmidt; H H Schild
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

5.  Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.

Authors:  Carolin Gramsch; Felix Nensa; Oliver Kastrup; Stefan Maderwald; Cornelius Deuschl; Adrian Ringelstein; Juliane Schelhorn; Michael Forsting; Marc Schlamann
Journal:  Acta Radiol       Date:  2014-05-27       Impact factor: 1.990

6.  Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging.

Authors:  G Iannucci; M Rovaris; L Giacomotti; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

7.  Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.

Authors:  Daniel M Harrison; Snehashis Roy; Jiwon Oh; Izlem Izbudak; Dzung Pham; Susan Courtney; Brian Caffo; Craig K Jones; Peter van Zijl; Peter A Calabresi
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

Review 8.  Measurement and clinical effect of grey matter pathology in multiple sclerosis.

Authors:  Jeroen J G Geurts; Massimiliano Calabrese; Elizabeth Fisher; Richard A Rudick
Journal:  Lancet Neurol       Date:  2012-12       Impact factor: 44.182

9.  Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".

Authors:  María I Gaitán; Paulina Yañes; Pascal Sati; Carlos Romero; Daniel S Reich; Jorge Correale
Journal:  Mult Scler       Date:  2015-11-09       Impact factor: 6.312

Review 10.  Gray matters in multiple sclerosis: cognitive impairment and structural MRI.

Authors:  Silvia Messina; Francesco Patti
Journal:  Mult Scler Int       Date:  2014-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.